<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Only rarely can the development of subretinal foveal or parafoveal neovascularization be observed in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report herein the clinical characteristics pertaining to neovascular membranes and the treatment thereof in 3 patients afflicted with either <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> (2 patients) or <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et syndrome (1 patient) </plain></SENT>
<SENT sid="2" pm="."><plain>Peroral steroids contributed to a reduction of neovascular membranes in 1 patient with <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The management of <z:hpo ids='HP_0000554'>uveitis</z:hpo> is mandatory for the prevention of subretinal foveal neovascular membranes </plain></SENT>
</text></document>